ARC Centre of Excellence in Convergent Bio-Nano Science and Technology

  • Davis, Thomas (Primary Chief Investigator (PCI))
  • Boyd, Benjamin (Chief Investigator (CI))
  • Bunnett, Nigel, (Chief Investigator (CI))
  • Caruso, Frank (Chief Investigator (CI))
  • Corrie, Simon Robert (Chief Investigator (CI))
  • Crampin, Edmund (Chief Investigator (CI))
  • Gooding, John (Chief Investigator (CI))
  • Johnston, Angus (Chief Investigator (CI))
  • Kavallaris, Maria (Chief Investigator (CI))
  • Kearnes, Matthew (Chief Investigator (CI))
  • Kent, Stephen (Chief Investigator (CI))
  • McGhee, John (Chief Investigator (CI))
  • Nann, Thomas (Chief Investigator (CI))
  • Parton, Robert (Chief Investigator (CI))
  • Porter, Christopher (Chief Investigator (CI))
  • Thordarson, Pall (Chief Investigator (CI))
  • Thurecht, Kristofer (Chief Investigator (CI))
  • Voelcker, Nicolas Hans (Chief Investigator (CI))
  • Whittaker, Andrew (Chief Investigator (CI))
  • Abbott, Nicholas (Partner Investigator (PI))
  • Alexander, Cameron (Partner Investigator (PI))
  • Dawson, Kenneth (Partner Investigator (PI))
  • Greguric, Ivan (Partner Investigator (PI))
  • Haddleton, David (Partner Investigator (PI))
  • Hawker, Craig (Partner Investigator (PI))
  • Lee, Doo Sung (Partner Investigator (PI))
  • Lewis, Jason (Partner Investigator (PI))
  • McLean, Keith (Partner Investigator (PI))
  • Stevens, Molly (Partner Investigator (PI))
  • Jones-Jayasinghe, Natalie, (Project Manager)
  • Thierry, Benjamin (Chief Investigator (CI))
  • Prestidge, Clive Allan (Chief Investigator (CI))

Project: Research

Project Description

The CoE in Convergent Bio-Nano Science &Technology comprises a multi-disciplinary team focused on
research aiming to understand and control the interface of materials with biological systems. The Centre will
exploit knowledge of the bio-nano interface to design materials that transport and deliver vaccines, drugs
and gene therapy agents, and to design new diagnostic agents and devices. Nanomedicines are on the cusp
of revolutionizing diagnosis and therapy in many diseases. The CoE will be the focus of bio-nano research
activity in Australia, uniting universities, research agencies, institutes and companies. The expected
outcomes are better diagnostic and therapeutic tools designed via an enhanced understanding of the bionano-
interface.
StatusActive
Effective start/end date30/06/1429/06/21

Funding

  • Australian Research Council (ARC): AUD1,890,000.00
  • Memorial Sloan Kettering Cancer Center
  • The University of Nottingham (UK)
  • University College Dublin
  • University of California
  • University of Warwick
  • University of Wisconsin-Madison
  • SungKyunKwan University
  • Australian Research Council (ARC): AUD1,890,000.00
  • Australian Research Council (ARC): AUD1,890,000.00
  • Australian Research Council (ARC): AUD945,000.00
  • Australian Research Council (ARC): AUD945,000.00
  • Australian Research Council (ARC): AUD1,108,422.00
  • Monash University
  • Australian Research Council (ARC): AUD17,329,578.00
  • The University of Melbourne
  • The University of New South Wales
  • The University of Queensland
  • University of South Australia
  • Australian Nuclear Science and Technology Organisation : AUD120,000.00
  • CSIRO Materials Science and Engineering (CMSE)
  • Imperial College London